Beauty Health price target raised to $4 from $3 at Stifel

Stifel raised the firm’s price target on Beauty Health to $4 from $3 and keeps a Hold rating on the shares. While Q4 “offered few surprises” given that components of the results were already pre-announced, the company’s 2024 guidance was “better than feared,” though it is back-end weighted, the analyst tells investors. Back-end weighted guidance “has tripped up Beauty Health in prior years,” so the firm will take “a wait and see approach” and reiterates a Hold rating, the analyst added.